Develops clinical-stage therapeutics for rare genetic diseases.
| Title |
|---|
| GondolaBio Service Co, Inc. - Scientist, Drug Discovery Full Time · $135K-$175K · 2+ YOE Palo Alto or San Francisco · Onsite |
| GondolaBio Service Co, Inc. - Senior Director, Clinical Operations Full Time · $244K-$295K · 12+ YOE Palo Alto, California, United States · Hybrid |
| GondolaBio Service Co, Inc. - Executive Administrator Full Time · $125K-$145K · 3+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Senior Scientist, Cell Biology Full Time · $155K-$175K · 3+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Vice President, CMC Analytical Full Time · $320K-$364K · 15+ YOE Palo Alto, California, United States · Hybrid |
| GondolaBio Service Co, Inc. - Director, CMC Process Development and Manufacturing Full Time · $220K-$250K · 10+ YOE San Francisco, California, United States · Hybrid |
| GondolaBio Service Co, Inc. - Director/Senior Director, DMPK Full Time · $255K-$285K · 5+ YOE Palo Alto or United States · Hybrid |
| GondolaBio Service Co, Inc. - Director, Analytical Development Full Time · $220K-$250K · 5+ YOE United States · Hybrid |
| GondolaBio Service Co, Inc. - Executive Director, Translational Medicine Full Time · $275K-$315K · 10+ YOE San Francisco, California, United States · Hybrid |
| GondolaBio Service Co, Inc. - Director, Quality Assurance Full Time · $220K-$250K · 10+ YOE United States · Remote |
| Senior Director, Analytical Development Full Time · $245K-$278K · 15+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Senior Director, Drug Product Development Full Time · $254K-$300K · 15+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Senior, Executive Assistant Full Time · $150K-$168K · 3+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Scientist I/II, Antibody Discovery Full Time · $100K-$140K · 2+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Associate Director, Translational Medicine Full Time · $185K-$215K · 8+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Assistant Controller Full Time · $185K-$250K · 10+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - SR, Clinical Trial Manager Full Time · $170K-$197K · 7+ YOE Palo Alto, California, United States · Remote |
| GondolaBio Service Co, Inc. - VP, Clinical Development Full Time · $336K-$370K · 15+ YOE Palo Alto or United States · Remote |
| GondolaBio Service Co, Inc. - Director, Toxicology Full Time · $220K-$250K · 10+ YOE United States · Remote |
| GondolaBio Service Co, Inc. - Vice President, Clinical Development Full Time · 10+ YOE United States · Remote |
| Senior/Principal Scientist, Oligonucleotide Discovery (siRNA/ASO) Full Time · $185K-$215K · 8+ YOE Palo Alto or Shanghai · Hybrid |
| GondolaBio Service Co, Inc. - Associate/ Director, Drug Substance Manufacturing Full Time · $188K-$213K · 10+ YOE Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Associate Director/Director/Sr. Director, Business Development & Operations Full Time · $200K-$295K Palo Alto, California, United States · Onsite |
| Associate/Senior Associate, Asset Acquisition Full Time · $130K-$165K Palo Alto, California, United States · Onsite |
| GondolaBio Service Co, Inc. - Associate, Asset Acquisition, GondolaBio Full Time · $130K-$170K Palo Alto, California, United States · Hybrid |
| Activities | Genetic therapeutics developmentClinical trial managementDrug discovery researchBiopharmaceutical asset acquisitionRare disease drug manufacturing |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | GondolaBio |
| Employees | 45 |
| Type | Private |
| Parent Company | BridgeBio |
| Subsidiaries | Portal Therapeutics |
| Tagline | Develops clinical-stage therapeutics for rare genetic diseases. |
| Founded | 2,024 |
| Website | gondolabio.com |
| Latest Funding Round | Corporate Round |
| Latest Funding Year | 2,024 |
| Latest Funding Amount | 300,000,000 |
| Latest Investors | Viking Global InvestorsPatient Square CapitalFrazier Life Sciences |